Predictors of Differential Response to Induction Therapy in High-Risk Neuroblastoma: A Report from the Children’s Oncology Group (COG)

por Pinto, Navin, Naranjo, Arlene, Hibbitts, Emily, Kreissman, Susan G., Granger, M. Meaghan, Irwin, Meredith S., Bagatell, Rochelle, London, Wendy B., Greengard, Emily G., Park, Julie R., DuBois, Steven G.
Publicado en Eur J Cancer (2019)

Association of MYCN Copy Number with Clinical Features, Tumor Biology, and Outcomes in Neuroblastoma: A Report from the Children’s Oncology Group

por Campbell, Kevin, Gastier-Foster, Julie M., Mann, Meegan, Naranjo, Arlene, Van Ryn, Collin, Bagatell, Rochelle, Matthay, Katherine K., London, Wendy B., Irwin, Meredith S., Shimada, Hiroyuki, Granger, M. Meaghan, Hogarty, Michael D., Park, Julie R., DuBois, Steven G.
Publicado en Cancer (2017)

Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer

por Mack, Jennifer W., Uno, Hajime, Twist, Clare J., Bagatell, Rochelle, Rosenberg, Abby R., Marachelian, Araz, Granger, M. Meaghan, Bender, Julia Glade, Baker, Justin N., Park, Julie R., Cohn, Susan L., Fernandez, Jorge H., Diller, Lisa R., Shusterman, Suzanne
Publicado en J Pain Symptom Manage (2020)

Unrealistic Parental Expectations for Cure in Poor-Prognosis Childhood Cancer

por Mack, Jennifer W., Cronin, Angel M., Uno, Hajime, Shusterman, Suzanne, Twist, Clare J., Bagatell, Rochelle, Rosenberg, Abby, Marachelian, Araz, Granger, M. Meaghan, Bender, Julia Glade, Baker, Justin N., Park, Julie, Cohn, Susan L., Levine, Alyssa, Taddei, Sarah, Diller, Lisa R.
Publicado en Cancer (2019)

Phase 1 Study of Vorinostat as a Radiation Sensitizer with (131)I-Metaiodobenzylguanidine ((131)I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

por DuBois, Steven G., Groshen, Susan, Park, Julie R., Haas-Kogan, Daphne A., Yang, Xiaodong, Geier, Ethan, Chen, Eugene, Giacomini, Kathy, Weiss, Brian, Cohn, Susan L., Granger, M. Meaghan, Yanik, Gregory A., Hawkins, Randall, Courtier, Jesse, Jackson, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Czarnecki, Scarlett, Tsao-Wei, Denice, Villablanca, Judith G., Marachelian, Araz, Matthay, Katherine K.
Publicado en Clin Cancer Res (2015)

Phase 2 Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

por DuBois, Steven G., Mosse, Yael P., Fox, Elizabeth, Kudgus, Rachel A., Reid, Joel M., McGovern, Renee, Groshen, Susan, Bagatell, Rochelle, Maris, John M., Twist, Clare J., Goldsmith, Kelly, Granger, M. Meaghan, Weiss, Brian, Park, Julie R., Macy, Margaret E., Cohn, Susan L., Yanik, Greg, Wagner, Lars, Hawkins, Randall, Courtier, Jesse, Lai, Hollie, Goodarzian, Fariba, Shimada, Hiroyuki, Boucher, Najee, Czarnecki, Scarlett, Luo, Chunqiao, Tsao-Wei, Denice D., Matthay, Katherine K., Marachelian, Araz
Publicado en Clin Cancer Res (2018)